Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Joseph Lonergan

    TitleClinical Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address200 W. Arbor Drive #8681
    CA San Diego 92103
    Phone619-543-3995
    vCardDownload vCard

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Zarrinpar A, Lin GY, Lonergan J. A rare cause of an ileocecal fistula in an AIDS patient. Gastrointestinal infection by Histoplasma capsulatum infection identified with internal transcribed spacer primer sets. Gastroenterology. 2013 Apr; 144(4):697, 857-8. PMID: 23499285; PMCID: PMC3648220.
      2. Cachay ER, Sitapati A, Caperna J, Freeborn K, Lonergan J, Jocson E, Mathews WC. Denial of risk behavior does not exclude asymptomatic anorectal sexually transmitted infection in HIV-infected men. PLoS One. 2009 Dec 30; 4(12):e8504. PMID: 20041143; PMCID: PMC2794382.
      3. Abra GE, Lonergan J. Reversible hepatic and lipid abnormalities with nonprescription anabolic-androgenic steroid use in 2 HIV-infected men. Clin Infect Dis. 2006 Jan 01; 42(1):151-2. PMID: 16323106.
        View in: PubMed
      4. McComsey GA, Paulsen DM, Lonergan J, Hessenthaler SM, Hoppel CL, Williams VC, Fisher RL, Cherry CL, White-Owen C, Thompson KA, Ross ST, Hernandez JE, Ross LL. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS. 2005 Jan 03; 19(1):15-23. PMID: 15627029.
        View in: PubMed
      5. McComsey G, Lonergan J. Mitochondrial dysfunction: patient monitoring and toxicity management. J Acquir Immune Defic Syndr. 2004 Sep 01; 37 Suppl 1:S30-5. PMID: 15319667.
        View in: PubMed
      6. Lonergan J, McComsey GA, Fisher RL, Shalit P, File TM, Ward DJ, Williams VC, Hessenthaler SM, Lindsey L, Hernandez JE. Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine. J Acquir Immune Defic Syndr. 2004 Aug 01; 36(4):935-42. PMID: 15220700.
        View in: PubMed
      7. McComsey GA, Ward DJ, Hessenthaler SM, Sension MG, Shalit P, Lonergan J, Fisher RL, Williams VC, Hernandez JE. Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study. Clin Infect Dis. 2004 Jan 15; 38(2):263-70. PMID: 14699460.
        View in: PubMed
      8. Lonergan J, Barber RE, Mathews WC. Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis. AIDS. 2003 Nov 21; 17(17):2495-9. PMID: 14600521.
        View in: PubMed
      9. Blanchard JN, Wohlfeiler M, Canas A, King K, Lonergan J. Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected]. Clin Infect Dis. 2003 Sep 01; 37(5):e57-62. PMID: 12942419.
        View in: PubMed